CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net income	$ 120,842	$ 511,678
Adjustments to reconcile net income to net cash provided from operating activities:
Deferred income tax (benefit) expense	(4,471)	134,192
Depletion, depreciation and amortization	174,735	171,578
Abandonment and impairment of unproved properties	3,895	33,296
Derivative fair value income	(63,406)	(491,701)
Cash settlements on derivative financial instruments	250,430	111,054
Divestiture contract obligation, including accretion	20,329	60,774
Amortization of deferred financing costs and other	2,425	2,594
Deferred and stock-based compensation	29,337	41,403
Gain on the sale of assets	(153)	(244)
Gain on early extinguishment of debt	(243)	(439)
Changes in working capital:
Accounts receivable	76,913	317,981
Other current assets	(22,405)	(2,998)
Accounts payable	(5,718)	(76,143)
Accrued liabilities and other	(101,805)	(211,479)
Net cash provided from operating activities	480,705	601,546
Investing activities:
Additions to natural gas properties	(286,098)	(277,088)
Additions to field service assets	(1,125)	(87)
Acreage purchases	(34,997)	(19,572)
Proceeds from disposal of assets	262	771
Purchases of marketable securities held by the deferred compensation plan	(36,113)	(39,346)
Proceeds from the sales of marketable securities held by the deferred compensation plan	41,939	43,663
Net cash used in investing activities	(316,132)	(291,659)
Financing activities:
Borrowings on credit facility	0	185,000
Repayments on credit facility	0	(204,000)
Repayment of senior notes	(66,069)	(60,934)
Dividends paid	(38,874)	(38,640)
Treasury stock purchases	(10,199)	(9,663)
Taxes paid for shares withheld	(25,169)	(39,150)
Change in cash overdrafts	(3,016)	(19,657)
Proceeds from the sales of common stock held by the deferred compensation plan	17,832	39,025
Net cash used in financing activities	(125,495)	(148,019)
Increase in cash and cash equivalents	39,078	161,868
Cash and cash equivalents at beginning of period	211,974	207
Cash and cash equivalents at end of period	$ 251,052	$ 162,075